- Email: [email protected]
Bios
William C. Dooley, MD, is the G. Rainey Williams Chair in Surgical Breast Oncology, Director of Surgical Oncology, and Medical Director of the University of Oklahoma Breast Institute. He attended medical school at Vanderbilt University, and completed internship and residency training in surgery and surgical oncology at Johns Hopkins University and at Oxford University in England. His research interests include ductal lavage as a screening tool for premalignant breast disease and the development of new breast cancer prognostic factors.
Lisa A. Newman, MD, MPH, is Associate Professor of Surgery and Director of the Breast Care Center at the University of Michigan. Her undergraduate and MPH degrees were obtained from Harvard University. She attended medical school and trained in general surgery at the State University of New York Downstate Medical Center. She completed her surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center. Dr. Newman’s research interest is breast cancer risk assessment, including the evaluation of risk in diverse ethnic populations. Kenneth A. Kern, MD, is Clinical Professor of Surgery and Surgical Oncology at Hartford Hospital and the University of Connecticut School of Medicine in Hartford, Connecticut. He received his medical degree from Harvard Medical School. Dr. Kern completed a residency in general surgery at the Johns Hopkins Hospital and a fellowship in surgical oncology at the National Cancer Institute. His research interests involve the clinical application of sentinel node biopsy in breast cancer, melanoma, and other malignancies.
Curr Probl Surg, April 2004
391
Henry Mark Kuerer, MD, PhD, is Associate Professor of Surgical Oncology and Director of the Breast Surgical Oncology Training Program at the University of Texas M.D. Anderson Cancer Center. He received his doctoral degrees from the State University of New York at Brooklyn and his general surgery residency was completed at the Mount Sinai School of Medicine in New York City. He is active in all aspects of breast cancer treatment and research and is the Chair of the American College of Surgeons Oncology Group Education Committee.
Pat W. Whitworth, MD, is Director of the Nashville Breast Cancer and Vice-Chair of the Breast Organ Site Working Group for the American College of Surgeons Oncology Group. After attending the University of Tennessee College of Medicine and completing surgery residency at the University of Louisville School of Medicine, he completed a fellowship in surgical oncology at the M.D. Anderson Cancer Center. He participated in the first multi-institutional trial to validate sentinel node staging for breast cancer. Dr. Whitworth is Co-Director of the American College of Surgeons breast ultrasound course for fall, 2003 and spring, 2004. S. Eva Singletary, M.D., is Professor of Surgical Oncology at The University of Texas M.D. Anderson Cancer Center. She received her medical training at the Medical University of South Carolina, and completed a fellowship at the University of Texas M.D. Anderson Cancer Center. She is the current Chair of the American Joint Committee on Cancer Breast Task Force, which recently completed revisions to the staging system for breast cancer. Dr. Singletary is the 2003 President-Elect of the Society of Surgical Oncology, the Editor-In-Chief of Breast Diseases: A Year Book Quarterly, and breast section editor for Annals of Surgical Oncology and Cancer.
392
Curr Probl Surg, April 2004
Kambiz Dowlatshahi, MD, is Professor of Surgery at Rush University, Chicago, Illinois. He was born in Iran, received his medical training at St. Mary’s Hospital, University of London, and then immigrated to the United States. Dr. Dowlatshahi introduced the first stereotactic unit for needle biopsy of mammographically detected breast lesions in the United States. At Rush University, Dr. Dowlatshahi began to test the concept of interstitial laser therapy, first in animal tumors, then in patients with liver tumors, and finally in mammographically detected breast cancers.
Rache M. Simmons, MD, is Associate Professor of Surgery at the New York Presbyterian Hospital, Weill Medical College of Cornell University. She is a PastPresident of the American Society of Breast Surgeons and the Breast Co-Vice Chair of the American College of Surgeons Oncology Group. Dr. Simmons is the Director of Breast Cancer Surgical Research at Cornell University and is currently involved in multiple research studies investigating minimally invasive therapies for breast-cancer, including skin-sparing/ areola-sparing mastectomies and ablative techniques.
Scott T. Hollenbeck, MD, is currently a resident in general surgery at the New York Presbyterian Hospital, Weill Medical College of Cornell University Cornell. His clinical research has focused on surgical techniques for limited skin resection in patients with breast disease, including the skin-sparing and areola-sparing mastectomy.
Curr Probl Surg, April 2004
393
Lisa A. Newman, MD, MPH, is Associate Professor of Surgery and Director of the Breast Care Center at the University of Michigan. Her undergraduate and MPH degrees were obtained from Harvard University. She attended medical school and trained in general surgery at the State University of New York Downstate Medical Center. She completed her surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center. Dr. Newman’s research interest is breast cancer risk assessment, including the evaluation of risk in diverse ethnic populations. Kenneth A. Kern, MD, is Clinical Professor of Surgery and Surgical Oncology at Hartford Hospital and the University of Connecticut School of Medicine in Hartford, Connecticut. He received his medical degree from Harvard Medical School. Dr. Kern completed a residency in general surgery at the Johns Hopkins Hospital and a fellowship in surgical oncology at the National Cancer Institute. His research interests involve the clinical application of sentinel node biopsy in breast cancer, melanoma, and other malignancies.
Curr Probl Surg, April 2004
391
Henry Mark Kuerer, MD, PhD, is Associate Professor of Surgical Oncology and Director of the Breast Surgical Oncology Training Program at the University of Texas M.D. Anderson Cancer Center. He received his doctoral degrees from the State University of New York at Brooklyn and his general surgery residency was completed at the Mount Sinai School of Medicine in New York City. He is active in all aspects of breast cancer treatment and research and is the Chair of the American College of Surgeons Oncology Group Education Committee.
Pat W. Whitworth, MD, is Director of the Nashville Breast Cancer and Vice-Chair of the Breast Organ Site Working Group for the American College of Surgeons Oncology Group. After attending the University of Tennessee College of Medicine and completing surgery residency at the University of Louisville School of Medicine, he completed a fellowship in surgical oncology at the M.D. Anderson Cancer Center. He participated in the first multi-institutional trial to validate sentinel node staging for breast cancer. Dr. Whitworth is Co-Director of the American College of Surgeons breast ultrasound course for fall, 2003 and spring, 2004. S. Eva Singletary, M.D., is Professor of Surgical Oncology at The University of Texas M.D. Anderson Cancer Center. She received her medical training at the Medical University of South Carolina, and completed a fellowship at the University of Texas M.D. Anderson Cancer Center. She is the current Chair of the American Joint Committee on Cancer Breast Task Force, which recently completed revisions to the staging system for breast cancer. Dr. Singletary is the 2003 President-Elect of the Society of Surgical Oncology, the Editor-In-Chief of Breast Diseases: A Year Book Quarterly, and breast section editor for Annals of Surgical Oncology and Cancer.
392
Curr Probl Surg, April 2004
Kambiz Dowlatshahi, MD, is Professor of Surgery at Rush University, Chicago, Illinois. He was born in Iran, received his medical training at St. Mary’s Hospital, University of London, and then immigrated to the United States. Dr. Dowlatshahi introduced the first stereotactic unit for needle biopsy of mammographically detected breast lesions in the United States. At Rush University, Dr. Dowlatshahi began to test the concept of interstitial laser therapy, first in animal tumors, then in patients with liver tumors, and finally in mammographically detected breast cancers.
Rache M. Simmons, MD, is Associate Professor of Surgery at the New York Presbyterian Hospital, Weill Medical College of Cornell University. She is a PastPresident of the American Society of Breast Surgeons and the Breast Co-Vice Chair of the American College of Surgeons Oncology Group. Dr. Simmons is the Director of Breast Cancer Surgical Research at Cornell University and is currently involved in multiple research studies investigating minimally invasive therapies for breast-cancer, including skin-sparing/ areola-sparing mastectomies and ablative techniques.
Scott T. Hollenbeck, MD, is currently a resident in general surgery at the New York Presbyterian Hospital, Weill Medical College of Cornell University Cornell. His clinical research has focused on surgical techniques for limited skin resection in patients with breast disease, including the skin-sparing and areola-sparing mastectomy.
Curr Probl Surg, April 2004
393